Related Experiment Video
Updated: Feb 14, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
Apatinib as a third- or further- line treatment in patients with advanced NSCLC harboring wild-type EGFR
Shencun Fang1, Meiling Zhang2, Guihong Wei3
1Department of Respiratory Medicine Center, Nanjing Chest Hospital, Nanjing, Jiangsu, China.
Objectives:
This study was conducted to evaluate the efficacy and safety of apatinib in advanced NSCLC patients with EGFR wild-type who have failed more than second-line chemotherapy.
Materials And Methods:
We retrospectively analyzed patients with EGFR wild-type advanced NSCLC who were treated with apatinib from January 2014 to August 2016. Objective response rate (ORR), disease control rate (DCR), progression free survival (PFS), overall survival (OS), and adverse events (AEs) were reveiwed and evaluated. Univariate and multivariate analyses were performed to determine the prognostic factors.
Results:
36 patients were evaluable for safety and efficacy. 6 patients obtained partial response, and 21 showed stable disease. The ORR and DCR were 16.7% and 75%, respectively. The median PFS and OS were 4.5 months and 8.2 months, respectively. Prognostic variable for a longer OS was good performance status (p = 0.015). Most adverse reactions were mild or moderate.
Conclusions:
Apatinib should be recommended as a third- or further- line therapy in advanced NSCLC patients with EGFR wild-type due to its better efficacy and tolerable toxicity.
Insights
Apatinib shows efficacy in advanced non-small cell lung cancer (NSCLC) patients with EGFR wild-type, offering a valuable third-line therapy option. This treatment demonstrated a 75% disease control rate with manageable side effects.
Area of Science:
- Oncology
- Pharmacology
Background:
- Advanced non-small cell lung cancer (NSCLC) with EGFR wild-type often presents treatment challenges after multiple chemotherapy lines.
- Identifying effective salvage therapies is crucial for improving patient outcomes in this refractory population.
Purpose of the Study:
- To evaluate the efficacy and safety of apatinib as a third- or further-line treatment for advanced NSCLC patients with EGFR wild-type.
- To determine prognostic factors influencing survival in this patient cohort.
Main Methods:
- Retrospective analysis of 36 EGFR wild-type advanced NSCLC patients treated with apatinib (January 2014 - August 2016).
- Evaluation of objective response rate (ORR), disease control rate (DCR), progression-free survival (PFS), overall survival (OS), and adverse events (AEs).
- Univariate and multivariate analyses to identify prognostic variables.
Main Results:
- The objective response rate (ORR) was 16.7% and the disease control rate (DCR) was 75%.
- Median progression-free survival (PFS) was 4.5 months, and median overall survival (OS) was 8.2 months.
- Good performance status was a significant prognostic factor for longer OS (p = 0.015); most adverse events were mild to moderate.
Conclusions:
- Apatinib demonstrates promising efficacy and tolerable toxicity in advanced NSCLC patients with EGFR wild-type who have failed multiple prior therapies.
- Apatinib is recommended as a third- or further-line treatment option for this patient population.
- Further prospective studies may validate these findings and optimize treatment strategies.
More Related Videos
Related Concept Videos
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Extraction: Advanced Methods
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Types of Hormones
Sample Preparation for Analysis: Advanced Techniques
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
Types of Selection

